Global and focal white matter integrity in breast cancer survivors 20 years after adjuvant chemotherapy

Human Brain Mapping

Volumn 35, Issue 3, 2014, Pages 889-899

  Koppelmans, Vincent ^a,b   de Groot, Marius ^a   de Ruiter, Michiel B ^b,c   Boogerd, Willem ^b   Seynaeve, Caroline ^a   Vernooij, Meike W ^a   Niessen, Wiro J ^a,d   Schagen, Sanne B ^b   Breteler, Monique M B ^a,e,f  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

^e GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^f UNIVERSITY OF BONN   (Germany)

Author keywords

Adjuvant; Axons; Brain; Breast neoplasms; Chemotherapy; Diffusion tensor imaging; Magnetic resonance imaging; Time

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE;

ADJUVANT CHEMOTHERAPY; AGED; BRAIN; BREAST NEOPLASMS; CHEMICALLY INDUCED; CROSS-SECTIONAL STUDY; DEVICES; DIFFUSION TENSOR IMAGING; DRUG EFFECTS; FEMALE; HUMAN; LEUKOENCEPHALOPATHY; MIDDLE AGED; PATHOLOGY; PROCEDURES; SURVIVOR; TIME;

AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CROSS-SECTIONAL STUDIES; CYCLOPHOSPHAMIDE; DIFFUSION TENSOR IMAGING; FEMALE; FLUOROURACIL; HUMANS; LEUKOENCEPHALOPATHIES; METHOTREXATE; MIDDLE AGED; SURVIVORS; TIME FACTORS;

EID: 84893726429     PISSN: 10659471     EISSN: 10970193     Source Type: Journal    
DOI: 10.1002/hbm.22221     Document Type: Article

References (49)

1. Abraham J, Haut MW, Moran MT, Filburn S, Lemiuex S, Kuwabara H (2008): Adjuvant chemotherapy for breast cancer: Effects on cerebral white matter seen in diffusion tensor imaging. Clin Breast Cancer 8:88-91.
2. Brown MS, Simon JH, Stemmer SM, Stears JC, Scherzinger A, Cagnoni PJ, Jones RB (1995): MR and proton spectroscopy of white matter disease induced by high-dose chemotherapy with bone marrow transplant in advanced breast carcinoma. AJNR Am J Neuroradiol 16:2013-2020.
3. Brown MS, Stemmer SM, Simon JH, Stears JC, Jones RB, Cagnoni PJ, Sheeder JL (1998): White matter disease induced by high-dose chemotherapy: Longitudinal study with MR imaging and proton spectroscopy. AJNR Am J Neuroradiol 19:217-221.
4. Centers for Disease C, Prevention (2011): Cancer survivors-United States, 2007. MMWR Morb Mortal Wkly Rep 60:269-272.
5. Choi SM, Lee SH, Yang YS, Kim BC, Kim MK, Cho KH (2001): 5-fluorouracil-induced leukoencephalopathy in patients with breast cancer. J Korean Med Sci 16:328-334.
6. Correa DD, Ahles TA (2008): Neurocognitive changes in cancer survivors. Cancer J 14:396-400.
7. D'Agostino RB, Sr., Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB (2008): General cardiovascular risk profile for use in primary care: The Framingham Heart Study. Circulation 117:743-753.
8. de Ruiter MB, Reneman L, Boogerd W, Veltman DJ, Caan M, Douaud G, Lavini C, Linn SC, Boven E, van Dam FS, Schagen SB. Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging. Hum Brain Mapp (in press).
9. de Zubicaray GI, Rose SE, McMahon KL (2011): The structure and connectivity of semantic memory in the healthy older adult brain. Neuroimage 54:1488-1494.
10. Deprez S, Amant F, Smeets A, Peeters R, Leemans A, Van Hecke W, Verhoeven JS, Christiaens MR, Vandenberghe J, Vandenbulcke M, Sunaert S (2011a): Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning. J Clin Oncol.
11. Deprez S, Amant F, Yigit R, Porke K, Verhoeven J, Van den Stock J, Smeets A, Christiaens MR, Leemans A, Van Hecke W, Vandenberghe J, Vandenbulcke M, Sunaert S (2011b): Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients. Hum Brain Mapp 32:480-493.
12. Froklage FE, Reijneveld JC, Heimans JJ (2011): Central neurotoxicity in cancer chemotherapy: Pharmacogenetic insights. Pharmacogenomics 12:379-395.
13. Gregorios JB, Gregorios AB, Mora J, Marcillo A, Fojaco RM, Green B (1989): Morphologic alterations in rat brain following systemic and intraventricular methotrexate injection: Light and electron microscopic studies. J Neuropathol Exp Neurol 48:33-47.
14. Han R, Dietrich J, Yang M, Mayer-Pröschel M, Noble M (2012). Studies of the Biology and Protection of Adverse Neurological Effects of Systemic Chemotherapy Treatment in Animal Models. Paris, France.
15. Han R, Yang YM, Dietrich J, Luebke A, Mayer-Proschel M, Noble M (2008): Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system. J Biol 7:12.
16. Hofman A, Breteler MM, van Duijn CM, Janssen HL, Krestin GP, Kuipers EJ, Stricker BH, Tiemeier H, Uitterlinden AG, Vingerling JR, Witteman JC (2009): The Rotterdam Study: 2010 objectives and design update. Eur J Epidemiol 24:553-572.
17. Hooning MJ, Dorresteijn LD, Aleman BM, Kappelle AC, Klijn JG, Boogerd W, van Leeuwen FE (2006): Decreased risk of stroke among 10-year survivors of breast cancer. J Clin Oncol 24:5388-5394.
18. Ikram MA, van der Lugt A, Niessen WJ, Krestin GP, Koudstaal PJ, Hofman A, Breteler MM, Vernooij MW (2011): The Rotterdam Scan Study: Design and update up to 2012. Eur J Epidemiol 26:811-824.
19. Ikram MA, Vrooman HA, Vernooij MW, den Heijer T, Hofman A, Niessen WJ, van der Lugt A, Koudstaal PJ, Breteler MM (2010): Brain tissue volumes in relation to cognitive function and risk of dementia. Neurobiol Aging 31:378-386.
20. Inagaki M, Yoshikawa E, Matsuoka Y, Sugawara Y, Nakano T, Akechi T, Wada N, Imoto S, Murakami K, Uchitomi Y (2007): Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. Cancer 109:146-156.
21. Jenkinson M, Smith S (2001): A global optimisation method for robust affine registration of brain images. Med Image Anal 5:143-156.
22. Kantarci K, Senjem ML, Avula R, Zhang B, Samikoglu AR, Weigand SD, Przybelski SA, Edmonson HA, Vemuri P, Knopman DS, Boeve BF, Ivnik RJ, Smith GE, Petersen RC, Jack CR, Jr. (2011): Diffusion tensor imaging and cognitive function in older adults with no dementia. Neurology 77:26-34.
23. Klein S, Staring M, Murphy K, Viergever MA, Pluim JP (2010): Elastix: A toolbox for intensity-based medical image registration. IEEE Trans Med Imaging 29:196-205.
24. Koppelmans V, Breteler MMB, Boogerd W, Seynaeve C, Gundy C, Schagen SB (2012a): Neuropsychological performance in breast cancer survivors more than 20 years after adjuvant chemotherapy. J Clin Oncol 30:1080-1086.
25. Koppelmans V, de Ruiter MB, van der Lijn F, Boogerd W, Seynaeve C, van der Lugt A, Vrooman H, Niessen WJ, Breteler MMB, Schagen SB (2012b): Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy. Breast Cancer Res Treat 132:1099-1106.
26. Leemans A, Jeurissen B, Sijbers J, Jones DK (2009). ExploreDTI: A graphical toolbox for processing, analyzing, and visualizing diffusion MR data. In: 17th Annual Meeting of Intl Soc Mag Reson Med. Hawaii, USA. p 3537.
27. Leemans A, Jones DK (2009): The B-matrix must be rotated when correcting for subject motion in DTI data. Mag Reson Med 61:1336-1349.
28. McDonald BC, Conroy SK, Ahles TA, West JD, Saykin AJ (2010): Gray matter reduction associated with systemic chemotherapy for breast cancer: A prospective MRI study. Breast Cancer Res Treat 123:819-828.
29. Mori S, Zhang J (2006): Principles of diffusion tensor imaging and its applications to basic neuroscience research. Neuron 51:527-539.
30. Muldoon LL, Soussain C, Jahnke K, Johanson C, Siegal T, Smith QR, Hall WA, Hynynen K, Senter PD, Peereboom DM, Neuwelt EA (2007): Chemotherapy delivery issues in central nervous system malignancy: A reality check. J Clin Oncol 25:2295-2305.
31. Neuwelt E, Abbott NJ, Abrey L, Banks WA, Blakley B, Davis T, Engelhardt B, Grammas P, Nedergaard M, Nutt J, Pardridge W, Rosenberg GA, Smith Q, Drewes LR (2008): Strategies to advance translational research into brain barriers. Lancet Neurol 7:84-96.
32. Nichols TE, Holmes AP (2002): Nonparametric permutation tests for functional neuroimaging: A primer with examples. Hum Brain Mapp 15:1-25.
33. Radloff LS (1977): The CES-D scale: A self report depression scale for research in the general population. Appl Psychol Meas 1:385-401.
34. Salat DH, Williams VJ, Leritz EC, Schnyer DM, Rudolph JL, Lipsitz LA, McGlinchey RE, Milberg WP (2012): Inter-individual variation in blood pressure is associated with regional white matter integrity in generally healthy older adults. Neuroimage 59:181-192.
35. Sant M, Francisci S, Capocaccia R, Verdecchia A, Allemani C, Berrino F (2006): Time trends of breast cancer survival in Europe in relation to incidence and mortality. Int J Cancer 119:2417-2422.
36. Seigers R, Fardell JE (2011): Neurobiological basis of chemotherapy-induced cognitive impairment: A review of rodent research. Neurosci Biobehav Rev 35:729-741.
37. Seigers R, Schagen SB, Coppens CM, van der Most PJ, van Dam FS, Koolhaas JM, Buwalda B (2009): Methotrexate decreases hippocampal cell proliferation and induces memory deficits in rats. Behav brain Res 201:279-284.
38. Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE, Watkins KE, Ciccarelli O, Cader MZ, Matthews PM, Behrens TE (2006): Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data. Neuroimage 31:1487-1505.
39. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H, Bannister PR, De Luca M, Drobnjak I, Flitney DE, Niazy RK, Saunders J, Vickers J, Zhang Y, De Stefano N, Brady JM, Matthews PM (2004): Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23:S208-S219.
40. Smith SM, Nichols TE (2009): Threshold-free cluster enhancement: Addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage 44:83-98.
41. Song SK, Sun SW, Ramsbottom MJ, Chang C, Russell J, Cross AH (2002): Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage 17:1429-1436.
42. Song SK, Yoshino J, Le TQ, Lin SJ, Sun SW, Cross AH, Armstrong RC (2005): Demyelination increases radial diffusivity in corpus callosum of mouse brain. Neuroimage 26:132-140.
43. van Dam FS, Schagen SB, Muller MJ, Boogerd W, vd Wall E, Droogleever Fortuyn ME, Rodenhuis S (1998): Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: High-dose versus standard-dose chemotherapy. J Natl Cancer Inst 90:210-218.
44. Vernooij MW, Ikram MA, Vrooman HA, Wielopolski PA, Krestin GP, Hofman A, Niessen WJ, Van der Lugt A, Breteler MM (2009): White matter microstructural integrity and cognitive function in a general elderly population. Arch Gen Psychiatry 66:545-553.
45. Vrooman HA, Cocosco CA, van der Lijn F, Stokking R, Ikram MA, Vernooij MW, Breteler MM, Niessen WJ (2007): Multi-spectral brain tissue segmentation using automatically trained k-nearest-neighbor classification. Neuroimage 37:71-81.
46. Wefel JS, Vardy J, Ahles T, Schagen SB (2011): International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol.
47. Wheeler-Kingshott CA, Cercignani M (2009): About "axial" and "radial" diffusivities. Mag Reson Med 61:1255-1260.
48. Yamada TH, Denburg NL, Beglinger LJ, Schultz SK (2010): Neuropsychological outcomes of older breast cancer survivors: Cognitive features ten or more years after chemotherapy. J Neuropsychiatry Clin Neurosci 22:48-54.
49. Ystad M, Hodneland E, Adolfsdottir S, Haasz J, Lundervold AJ, Eichele T, Lundervold A (2011): Cortico-striatal connectivity and cognition in normal aging: A combined DTI and resting state fMRI study. Neuroimage 55:24-31.